株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

乳がん治療薬の世界市場:産業分析、地域別の見通し、応用可能性、価格動向、競合市場シェア、予測

Breast Cancer Therapeutics Market Size By Product, By Distribution Channel, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

発行 Global Market Insights Inc. 商品コード 820611
出版日 ページ情報 英文 150 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.34円で換算しております。
Back to Top
乳がん治療薬の世界市場:産業分析、地域別の見通し、応用可能性、価格動向、競合市場シェア、予測 Breast Cancer Therapeutics Market Size By Product, By Distribution Channel, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025
出版日: 2019年03月01日 ページ情報: 英文 150 Pages
概要

当レポートでは、世界の乳がん治療薬市場について調査分析し、産業の考察、セグメント別の市場分析、地域別の分析、主要企業など、体系的な情報を提供しています。

第1章 調査手法・範囲

第2章 エグゼクティブサマリー

第3章 乳がん治療薬市場:産業の考察

  • 産業区分
  • 産業情勢
  • 産業影響力
  • 疫学情勢
  • 成長可能性分析
  • パイプライン分析
  • ファイブフォース分析
  • 企業の市場シェア分析
  • PESTEL分析

第4章 乳がん治療薬市場:製品別

  • 主要動向
  • ホルモン剤
  • 化学療法薬
  • 標的薬治療

第5章 乳がん治療薬市場:流通経路別

  • 主要動向
  • 病院
  • ASC
  • クリニック
  • Eコマース
  • 小売薬局

第6章 乳がん治療薬市場:地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 企業プロファイル

  • AstraZeneca
  • エーザイ
  • Eli Lilly
  • Roche Diagnostics
  • Novartis AG
  • Pfizer
  • Celgene
  • Sanofi
  • Teva Pharmaceutical
図表

Data Tables

  • TABLE 1. Breast cancer therapeutics industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Global breast cancer therapeutics market, 2014 - 2025 (USD Million)
  • TABLE 3. Global breast cancer therapeutics market, by product, 2014-2025 (USD Million)
  • TABLE 4. Global breast cancer therapeutics market, by distribution channel, 2014-2025 (USD Million)
  • TABLE 5. Global breast cancer therapeutics market, by region, 2014-2025 (USD Million)
  • TABLE 6. Industry impact forces
  • TABLE 7. Breast cancer therapeutics pipeline overview
  • TABLE 8. Hormone drugs market, by region, 2014 - 2025, (USD Million)
  • TABLE 9. Chemotherapy drugs market, by region, 2014 - 2025, (USD Million)
  • TABLE 10. Targeted drug therapy market, by region, 2014 - 2025, (USD Million)
  • TABLE 11. Hospitals market, by region, 2014 - 2025, (USD Million)
  • TABLE 12. Ambulatory surgical centers market, by region, 2014 - 2025, (USD Million)
  • TABLE 13. Clinics market, by region, 2014 - 2025, (USD Million)
  • TABLE 14. e-commerce market, by region, 2014 - 2025, (USD Million)
  • TABLE 15. Retail pharmacies market, by region, 2014 - 2025, (USD Million)
  • TABLE 16. North America breast cancer therapeutics market, by country 2014 - 2025 (USD Million)
  • TABLE 17. North America breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 18. North America breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 19. U.S. breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 20. U.S. breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 21. Canada breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 22. Canada breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 23. Europe breast cancer therapeutics market, by country 2014 - 2025 (USD Million)
  • TABLE 24. Europe breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 25. Europe breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 26. Germany breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 27. Germany breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 28. UK breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 29. UK breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 30. France breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 31. France breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 32. Spain breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 33. Spain breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 34. Italy breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 35. Italy breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 36. Russia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 37. Russia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 38. Poland breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 39. Poland breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 40. Asia Pacific Breast Cancer Therapeutics market, by country 2014 - 2025 (USD Million)
  • TABLE 41. Asia Pacific breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 42. Asia Pacific breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 43. Japan breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 44. Japan breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 45. China breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 46. China breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 47. India breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 48. India breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 49. Australia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 50. Australia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 51. Malaysia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 52. Malaysia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 53. Indonesia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 54. Indonesia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 55. Thailand breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 56. Thailand breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 57. Latin America Breast Cancer Therapeutics market, by country 2014 - 2025 (USD Million)
  • TABLE 58. Latin America breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 59. Latin America breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 60. Mexico breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 61. Mexico breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 62. Brazil breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 63. Brazil breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 64. Argentina breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 65. Argentina breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 66. MEA breast cancer therapeutics market, by country 2014 - 2025 (USD Million)
  • TABLE 67. MEA breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 68. MEA breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 69. South Africa breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 70. South Africa breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 71. UAE breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 72. UAE breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 73. Qatar breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 74. Qatar breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 75. Saudi Arabia breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 76. Saudi Arabia breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 77. Kuwait breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 78. Kuwait breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 79. Egypt breast cancer therapeutics market, by product, 2014 - 2025 (USD Million)
  • TABLE 80. Egypt breast cancer therapeutics market, by distribution channel, 2014 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global breast cancer therapeutics market, 2014- 2025 (USD Million)
  • FIG. 3 Age adjusted female breast cancer incidence rates, U.S., 2004 & 2014
  • FIG. 4 Growth potential analysis, by product
  • FIG. 5 Growth potential analysis, by distribution channel
  • FIG. 6 Porter's analysis
  • FIG. 7 Company share analysis, 2017
  • FIG. 8 Strategic dashboard, 2017
  • FIG. 9 PESTEL analysis
  • FIG. 10 Breast cancer therapeutics market share by product, 2018 & 2025
  • FIG. 11 Breast cancer therapeutics market share by distribution channel, 2018 & 2025
  • FIG. 12 Breast cancer therapeutics market share, by region, 2018 & 2025
目次
Product Code: 466

Title:
Breast Cancer Therapeutics Market Size By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centres, Clinics, e-commerce, Retail Pharmacies), Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Poland, China, India, Japan, India, Australia, Malaysia, Indonesia, Thailand, Brazil, Mexico, Argentina, South Africa, UAE, Qatar, Saudi Arabia, Kuwait, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025.

Breast Cancer Therapeutics Market will exceed USD 30,637.7 million by 2025; as per a new research report.

Increase in breast cancer prevalence in the developed regions across the globe will enhance the growth of breast cancer therapeutics market growth in the near future. In 2017, approximately 252,710 new cases of invasive breast cancer are anticipated to be detected in women in the Unites States with over 63,410 non-invasive breast cancer new cases. The growing adoption of western lifestyle in developing nations is an important cause for the increase of breast cancer incidence in these countries.

Presence of favorable insurance and reimbursement policies can drive the breast cancer therapeutics market. Managing the increasing cost of breast cancer therapeutics driven by the surge in both the quantity and price of targeted therapy drugs is challenging, since anticancer drugs can be remunerated under the pharmacy or medical benefit, based on their mode of administration.

High cost of the breast cancer therapeutics will be a major market impeding factor. The treatment cost for breast cancer is higher for patients that are not covered by insurance. According to a study, uninsured cancer patients pay approximately double as much for doctors' visits and 43 times more for chemotherapy drugs in comparison to what Medicare and private insurance pays.

Targeted drug therapy market held majority market share and was valued around USD 11,559.6 million in the year 2018. Recent technological advancements has resulted in growing demand for effective breast cancer treatment, stimulating rise in R&D investment for developing effective targeted breast cancer therapy. Hence, boosting the industry growth in the upcoming years.

The distribution of breast cancer therapeutics via retail pharmacies is estimated to grow at a CAGR of 9.7% over the projection period. There is a shift from specialty to retail pharmacies due to reimbursement variations and prolonged usage of oral formulations, particularly for targeted drug therapies thereby, boosting business growth.

Germany dominated the Europe breast cancer therapeutics market growth and was valued around USD 1,318.2 million in the year 2018. Increasing healthcare expenditure in Germany accounting for 11.3% of its GDP in 2014 will minimize the cost burden associated with the disease further propelling the market growth over the forecast period.

China breast cancer therapeutics market is estimated to grow at 13.7% over the projection period. The robust healthcare reforms need to be improved for diagnosis and treatment of breast cancer. However, increasing prevalence, and robust economic growth in China will drive breast cancer therapeutics market growth in the near future.

Industry players having a strong foothold include AstraZeneca, Roche Diagnostics, Pfizer, Novartis, Eisai, Eli Lilly, Sanofi, and Celgene. Other notable participants include Breas Medical, MAQUET and Drager, etc. To expand their industry presence, many established firms are entering in sparsely addressed high potential regions. Introduction of devices in emerging economies by these companies enables them to cater to unmet needs and expand revenue sources.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Breast cancer therapeutics industry 360 degree synopsis, 2014 - 2025 (USD Million)
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Distribution channel trends
    • 2.1.4. Regional trends

Chapter 3. Breast Cancer Therapeutics Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025 (USD Million)
  • 3.3. Industry impact factors
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing breast cancer prevalence in the developed countries
      • 3.3.1.2. Advancements in cancer biology
      • 3.3.1.3. Launch of several diagnostic and screening programs worldwide
      • 3.3.1.4. Favorable insurance and reimbursement policies
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. High cost of breast cancer therapeutics
  • 3.4. Epidemiology landscape
    • 3.4.1. U.S
    • 3.4.2. Europe
  • 3.5. Growth potential analysis
    • 3.5.1. By product
    • 3.5.2. By distribution channel
  • 3.6. Pipeline analysis
  • 3.7. Porter's analysis
  • 3.8. Company market share analysis, 2017
    • 3.8.1. Strategy dashboard
  • 3.9. PESTEL analysis

Chapter 4. Breast Cancer Therapeutics Market, By Product

  • 4.1. Global breast cancer therapeutics market share by product, 2018 & 2025
  • 4.2. Hormone drugs
    • 4.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.3. Chemotherapy drugs
    • 4.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.4. Targeted drug therapy
    • 4.4.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Breast cancer therapeutics Market, By Distribution channel

  • 5.1. Global breast cancer therapeutics market share by distribution channel, 2018 & 2025
  • 5.2. Hospitals
    • 5.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.4. Clinics
    • 5.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.5. e-commerce
    • 5.5.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.6. Retail pharmacies
    • 5.6.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Breast cancer therapeutics Market, By Region

  • 6.1. Global breast cancer therapeutics market share by region, 2018 & 2025
  • 6.2. North America
    • 6.2.1. Market size, by country, 2014 - 2025 (USD Million)
    • 6.2.2. Market size, by product, 2014 - 2025 (USD Million)
    • 6.2.3. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.2.4. U.S.
      • 6.2.4.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.2.4.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.2.5. Canada
      • 6.2.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.2.5.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market size, by country, 2014 - 2025 (USD Million)
    • 6.3.2. Market size, by product, 2014 - 2025 (USD Million)
    • 6.3.3. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.3.4.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.3.5. UK
      • 6.3.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.3.5.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.3.6. France
      • 6.3.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.3.6.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.3.7. Spain
      • 6.3.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.3.7.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.3.8. Italy
      • 6.3.8.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.3.8.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.3.9. Russia
      • 6.3.9.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.3.9.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.3.10. Poland
      • 6.3.10.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.3.10.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market size, by country, 2014 - 2025 (USD Million)
    • 6.4.2. Market size, by product, 2014 - 2025 (USD Million)
    • 6.4.3. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.4.4. China
      • 6.4.4.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.4.4.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.4.5. Japan
      • 6.4.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.4.5.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.4.6. India
      • 6.4.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.4.6.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.4.7.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.4.8. Australia
      • 6.4.8.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.4.8.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.4.9. Malaysia
      • 6.4.9.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.4.9.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.4.10. Indonesia
      • 6.4.10.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.4.10.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.4.11. Thailand
      • 6.4.11.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.4.11.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Market size, by country, 2014 - 2025 (USD Million)
    • 6.5.2. Market size, by product, 2014 - 2025 (USD Million)
    • 6.5.3. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.5.4. Brazil
      • 6.5.4.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.5.4.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.5.5. Mexico
      • 6.5.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.5.5.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.5.6. Argentina
      • 6.5.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.5.6.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Market size, by country, 2014 - 2025 (USD Million)
    • 6.6.2. Market size, by product, 2014 - 2025 (USD Million)
    • 6.6.3. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.6.4.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.6.5. Saudi Arabia
      • 6.6.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.6.5.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.6.6. UAE
      • 6.6.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.6.6.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.6.7. Qatar
      • 6.6.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.6.7.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.6.8. Kuwait
      • 6.6.8.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.6.8.2. Market size, by distribution channel, 2014 - 2025 (USD Million)
    • 6.6.9. Egypt
      • 6.6.9.1. Market size, by product, 2014 - 2025 (USD Million)
      • 6.6.9.2. Market size, by distribution channel, 2014 - 2025 (USD Million)

Chapter 7. Company Profiles

  • 7.1. AstraZeneca
    • 7.1.1. Business overview
    • 7.1.2. Financial data
    • 7.1.3. Product landscape
    • 7.1.4. Strategic outlook
    • 7.1.5. SWOT analysis
  • 7.2. Eisai Co., Ltd.
    • 7.2.1. Business overview
    • 7.2.2. Financial data
    • 7.2.3. Product landscape
    • 7.2.4. Strategic outlook
    • 7.2.5. SWOT analysis
  • 7.3. Eli Lilly
    • 7.3.1. Business overview
    • 7.3.2. Financial data
    • 7.3.3. Product landscape
    • 7.3.4. Strategic outlook
    • 7.3.5. SWOT analysis
  • 7.4. Roche Diagnostics
    • 7.4.1. Business overview
    • 7.4.2. Financial data
    • 7.4.3. Product landscape
    • 7.4.4. Strategic outlook
    • 7.4.5. SWOT analysis
  • 7.5. Novartis AG
    • 7.5.1. Business overview
    • 7.5.2. Financial data
    • 7.5.3. Product landscape
    • 7.5.4. Strategic outlook
    • 7.5.5. SWOT analysis
  • 7.6. Pfizer
    • 7.6.1. Business overview
    • 7.6.2. Financial data
    • 7.6.3. Product landscape
    • 7.6.4. Strategic outlook
    • 7.6.5. SWOT analysis
  • 7.7. Celgene
    • 7.7.1. Business overview
    • 7.7.2. Financial data
    • 7.7.3. Product landscape
    • 7.7.4. Strategic outlook
    • 7.7.5. SWOT analysis
  • 7.8. Sanofi
    • 7.8.1. Business overview
    • 7.8.2. Financial data
    • 7.8.3. Product landscape
    • 7.8.4. Strategic outlook
    • 7.8.5. SWOT analysis
  • 7.9. Teva Pharmaceutical
    • 7.9.1. Business overview
    • 7.9.2. Financial data
    • 7.9.3. Product landscape
    • 7.9.4. Strategic outlook
    • 7.9.5. SWOT analysis
Back to Top